The state of Texas is accusing major pharmacy benefit managers and drug companies of colluding to raise the cost of insulin. Texas alleged drug manufacturers Eli Lilly, Novo Nordisk and Sanofi raise the price of insulin and then pay an undisclosed amount back to PBMs Optum Rx, Express Scripts and CVS Caremark through a quid […]
Texas Sues PBMs, Manufacturers over Insulin ‘Conspiracy’ Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Texas Sues PBMs, Manufacturers over Insulin ‘Conspiracy’ Read More »
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin. The FTC on Friday filed an antitrust and consumer-protection lawsuit against the three largest pharmacy-benefit managers, or PBMs, and affiliated businesses. The lawsuit said the firms profited
FTC Accuses Drug Middlemen of Inflating Insulin Prices Read More »
You are unauthorized to view this page.
FTC Accuses Drug Middlemen of Inflating Insulin Prices Read More »
California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the middlemen known as pharmacy benefit managers, or PBMs, whom many policymakers blame for the soaring cost of prescription drugs. PBMs have been under fire for years for alleged profiteering and anticompetitive conduct, but efforts to
California May Regulate and Restrict Pharmaceutical Brokers Read More »
You are unauthorized to view this page.
California May Regulate and Restrict Pharmaceutical Brokers Read More »
A new study is raising red flags about the composition of market power among pharmacy benefit managers, powerful middlemen in the drug supply chain that are facing heavy scrutiny for their alleged role in increasing U.S. drug costs. Just three PBMs — Caremark, owned by CVS Health; Express Scripts, owned by Cigna; and Optum Rx,
Major PBMs Could Be Zeroing in on Specific Payer Markets for Dominance, Study Suggests Read More »
You are unauthorized to view this page.
AMA Study: The 4 Largest PBMs Control 70% of the Market Nationally Read More »
The four largest pharmacy benefit managers in the U.S. control 70% of the national market, and most regional PBM markets are highly concentrated, according to new data from the American Medical Association (AMA). The study dived into 2022 data on commercial and Medicare Part D plans and found that CVS Health’s Caremark is the largest
AMA Study: The 4 Largest PBMs Control 70% of the Market Nationally Read More »
